For years, pharma companies relied on external partners to run key commercial operations like targeting, incentives, forecasting, and analytics. In  recent years, more companies have started to build Global Capability Centers (GCCs) to take ownership of analytics, sales operations, omnichannel, data management, and market access, either in-house or in hybrid models with partners. 

This shift raises key questions: What work should move in-house versus stay with partners? How many people are needed, at what cost, and under what operating model? What's driving the shift—cost, access to  talent, more control, or faster execution? And what barriers  still slow progress, from attrition and knowledge transfer to fragmented data and complex global structures? 

In this session, we will share findings from the TGaS GCC Landscape, focused on commercial organizations. We will cover how companies are setting up hubs, where they are located, what work they handle, how they are governed, and how they deliver value  beyond cost savings. We will also review  how peers rate their GCC teams against US-based teams and where companies plan to take offshoring next over the coming 12–24 months. 

Join us to see  where your organization stands, how you compare to peers, and what leading companies are doing to  build and scale in-house commercial capabilities.